WO2021011432 COMPOSITIONS AND METHODS FOR TREATING DEMENTIA WITH LEWY BODIES

Settings

Stemming

Single Family Member

Include NPL

Publication Number WO/2021/011432

Publication Date 21.01.2021

International Application No. PCT/US2020/041736

International Filing Date 12.07.2020

IPC

CPC

Applicants

Inventors

Agents

Priority Data

62/873,813

12.07.2019

Publication Language English (EN)

Filing Language English (EN)

Designated States

Title

(EN) COMPOSITIONS AND METHODS FOR TREATING DEMENTIA WITH LEWY BODIES

(FR) COMPOSITIONS ET PROCÉDÉS DESTINÉS AU TRAITEMENT DE LA DÉMENCE À CORPS DE LEWY

Abstract

(EN)

The present invention provides methods and compositions for treatment of Dementia with Lewy Bodies.

(FR)

La présente invention concerne des procédés et des compositions destinés au traitement de la démence à corps de Lewy.

Latest bibliographic data on file with the International Bureau

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
33	Heterocyclic compounds
395	having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435	having six-membered rings with one nitrogen as the only ring hetero atom
44	Non-condensed pyridines; Hydrogenated derivatives thereof
4427	containing further heterocyclic ring systems
4439	containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
33	Heterocyclic compounds
395	having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435	having six-membered rings with one nitrogen as the only ring hetero atom
44	Non-condensed pyridines; Hydrogenated derivatives thereof
445	Non-condensed piperidines, e.g. piperocaine
4523	containing further heterocyclic ring systems
4545	containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
33	Heterocyclic compounds
395	having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435	having six-membered rings with one nitrogen as the only ring hetero atom
47	Quinolines; Isoquinolines

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
33	Heterocyclic compounds
395	having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435	having six-membered rings with one nitrogen as the only ring hetero atom
44	Non-condensed pyridines; Hydrogenated derivatives thereof
4427	containing further heterocyclic ring systems
4439	containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
33	Heterocyclic compounds
395	having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435	having six-membered rings with one nitrogen as the only ring hetero atom
44	Non-condensed pyridines; Hydrogenated derivatives thereof
445	Non-condensed piperidines, e.g. piperocaine
4523	containing further heterocyclic ring systems
4545	containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine